DNA Framework-Programmed Ligand Positioning to Modulate the Targeting Performance.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Molecular Biology

Background:

• Effective nanomedicine targeting remains a challenge, with clinical trials showing insufficient drug concentration at target sites.
• The influence of ligand-modification patterns on nanovector targeting efficiency is not well understood.
• DNA nanostructures offer precise control over ligand presentation for targeted drug delivery.

Purpose of the Study:

• To investigate the impact of ligand-modification patterns, specifically ligand valence and spacing, on nanovector targeting.
• To establish nanovectors with homogeneous and precisely controlled ligand-modification patterns using DNA tetrahedrons.
• To evaluate the in vitro and in vivo targeting performance and therapeutic efficacy of these engineered nanovectors.

Main Methods:

• Utilized DNA tetrahedrons as scaffolds for site-specific modification with targeting ligands.
• Synthesized nanovectors with varying ligand valences and controlled nanoscale distances between ligands.
• Conducted in vitro and in vivo studies to assess nanovector targeting efficiency and anti-tumor activity.

Main Results:

• Increasing ligand quantity alone provided limited improvement in targeting efficiency.
• The spatial distance between ligands played a more critical role in enhancing nanovector targeting.
• Nanovectors with the largest ligand distance (approx. 156.55 Å) demonstrated optimal targeting and significant cytostatic effects on tumor cells.

Conclusions:

• Ligand-modification patterns, particularly inter-ligand spacing, are critical determinants of nanomedicine targeting efficacy.
• DNA nanostructures enable precise engineering of nanovectors for improved therapeutic outcomes.
• This study provides valuable guidance for optimizing nanomedicine design and development for enhanced tumor targeting.